Sequential isolation
The Donor Difference
Counting protocolGMP Mobilized Leukopak
Apheresis from healthy donors who received FDA-approved drugs to mobilize CD34+ HSPCs from bone marrow into peripheral blood, for large-scale CD34+ yields. Collected on the Spectra Optia® system into ACD-A at FDA-registered, IRB-approved facilities.
Product specifications
- Catalog numbers
- CG, mLP, RegH, FR, Full Pak · Full Pak 2
- Mobilization
- G-CSF 10 µg/kg/day SC × 5 days + plerixafor 240 µg/kg SC × 2 days
- Format
- Fresh, 2 Paks
- Anticoagulant
- ACD-A
- Viability
- ≥ 90%
- Fill volume
- ≥ 280 mL
- Sterility (USP <71>)
- No growth
- Shipping
- 2–8 °C, validated container with temperature logger
- Documentation
- Certificate of Analysis, Summary of Records
AllCells GMP mobilized difference
RUO to GMP, one product line
Develop your process on RUO material, then move to GMP without changing starting material.
99% deliverability
Avoid delays with a 99% deliverability rate for GMP products.
Up to 5 collections per donor
Repeat mobilized collections from the same donor keep manufacturing consistent.
Keep the same donor across batches
Donor Management Services
Find, screen and retain donors from a repository of highly characterized, HLA-typed donors with diverse demographics and clinical parameters, from R&D through commercialization.
Resources
Protocols, webinars and articles from our scientists. Technical questions go straight to the Customer Success Team.